Lv64
1920 积分 2023-01-17 加入
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
10小时前
已完结
Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor
8天前
已完结
A patent review of anticancer CDK2 inhibitors (2017–present)
1个月前
已完结
Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019)
1个月前
已完结
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020–present
1个月前
已完结
Antiviral actions of natural compounds against dengue virus RNA dependent RNA polymerase: insights from molecular dynamics and Gibbs free energy landscape
1个月前
已完结
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
1个月前
已完结
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2– Breast Cancer
2个月前
已完结
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
2个月前
已完结
Identification of an allosteric site on the E3 ligase adapter cereblon
2个月前
已完结
皖公网安备34019202002308
